LumiHeal® and Anti-inflammatory Regenerative Medicine (AIMED): a new management strategy for shortening wound healing and effective outcomes, from Repair 1.0 to Wound Regeneration 4.0

Abstract

Wound healing may require a long-standing period. As a result, patients, including their families and society, must sustain a relevant burden. Moreover, patients have to remain disabled also for a long time. Therefore, the healthcare service has to expend applicable costs. In the past, the Regeneration Medicine 3.0 represented the keystone for a holistic approach to wound management. However, there was also the need to consider the socio-economic impact on hospital costs and regional management spending review. Consequently, it is demanding to revise the care strategies for patients with skin wounds integrated into hospital-territory stewardship. In this regard, an innovative approach (Wound Regeneration 4.0) permitted to obtain exciting outcomes. Namely, an integrated protocol, combining anti-inflammatory, regenerative medicine, shortened the duration of wound healing, improved the quality of life of patients and family and significantly diminished the costs. In this context, the LumiHeal® gel associated with multi-LED light exerts a series of activities that actively promote wound healing. Moreover, LumiHeal® gel is active in all phases of wound healing and is effective on both chronic and acute wounds. The current outcomes suggest a multidisciplinary approach based on clinical, pharmacological, and economic issues that represent a point of departure for a new phase, such as the Wound Regeneration 4.0.